The overall prevalence of MSK pain in women is 71%, with perimenoapusal women demonstrating a higher risk for MSK pain than their premenopausal counterparts.
In this webinar you will learn about:
Hormonal changes at menopasue
Implications of hormonal changes on bones, joints and soft tissue
Inflammatory changes at menopause
Implications for management of MSK issues.